300199 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Hybio Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sales of chemically synthesized peptide drugs. Its products include atosiban, carbetocin, desmopressin, eptifibatide, ganirelix, glatiramer, terlipressin, octreotide, liraglutide, and trimetazidine tablets. The company was founded on April 2, 2003 and is headquartered in Shenzhen, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
300199 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company